News

My DaTscan Results Made My PD Diagnosis ‘Real’

When I was first diagnosed with Parkinson’s disease (PD) in 2015, I asked the neurologist if there was a definitive test to confirm a PD diagnosis. I mentioned a DaTscan, but he said the test is not entirely conclusive. He also indicated that DaTscan results likely would not change his prescribed course of treatment for me. His view was that the…

Continue Reading

News

Parkinson’s Patients Show Reduced Workforce Participation Even Before Diagnosis, Study Finds

Parkinson’s patients show less ability to participate in work life even in the early stages before they are diagnosed with the disease, a study shows. In combination with biochemical and genetic biomarkers, this finding may help identify patients at risk of developing this progressive neurodegenerative disease before motor symptoms occur, the researchers suggest. The study, “Reduced workforce participation 5 years…

Continue Reading

News

New Art Initiative Aims to Improve Understanding and Discussion of Parkinson’s Off Periods

A new initiative by Acorda Therapeutics uses art to help people with Parkinson’s disease recognize and communicate about their off-period experiences. The initiative, called Framing OFF Through Art, builds on Acorda’s Live Well. Do Tell program, launched earlier this year. Framing OFF Through Art includes artwork inspired by the experiences of patients with Parkinson’s and their caregivers. The artists who created the pieces…

Continue Reading

News

Phase 1 Trial to Explore RDN-929’s Safety in Treating Brain Diseases by Protecting Synapses

Rodin Therapeutics has started a Phase 1 clinical trial to explore the safety of its synthetic compound, RDN-929, to treat neurodegenerative diseases, including Alzheimer’s and Parkinson’s, by protecting synapses. The trial (NCT03668314), is designed to assess the safety, tolerability, pharmacokinetics — how the body affects a medicine — and pharmacodynamics — the interactions between the body and a compound — of single and multiple ascending…

Continue Reading

News

Caffeine Plus Coffee Compound Linked to Serotonin Help Protect Brain from Toxic Damage, Mouse Study Says

Two compounds found in coffee — caffeine and EHT, a fatty acid molecule derived from serotonin — work together to protect the brain from damage induced by alpha-synuclein, a study in mice reported. The study, “Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson’s disease and DLB,” was published in PNAS. Parkinson’s disease is characterized by alpha-synuclein aggregates.…

Continue Reading

News

Merger of New Mexico Parkinson’s Coalition, PMDAlliance Expected to Improve Patient Services

The recent merger of the New Mexico Parkinson’s Coalition (NMPC) and national nonprofit Parkinson & Movement Disorder Alliance (PMDAlliance) is expected to significantly boost support services for Parkinson’s patients in the New Mexico area, according to the organizations. “I’m a firm believer in mergers when the organizations share similar missions and are compatible in their purpose and goals,” Sarah Jones, CEO of…

Continue Reading

News

New Neurodegeneration Challenge Network Puts Focus on Causes of Parkinson’s, Other Disorders

A new network launched by Facebook CEO Mark Zuckerberg and his wife, Priscilla Chan, will unite leading investigators from various biomedical fields, as well as biologists and physicians, in gaining insight into why neurodegenerative disorders such as Parkinson’s occur. The Chan Zuckerberg Initiative’s (CZI) Neurodegeneration Challenge Network will focus on neurodegenerative diseases as a group of disorders that share common features — and…

Continue Reading

News

Chinese Herbal Medicine Can Ease Brain Inflammation and Protect Neurons, Mice Study Reports

A concoction made from several Chinese herbal medicines helped reduce brain inflammation and promoted nerve cell survival in a mouse model of Parkinson’s disease, a study finds. The study, “Curative Anti-Inflammatory Properties of Chinese Optimized Yinxieling Formula in Models of Parkinson’s Disease,” was published in Evidence-Based Complementary and Alternative Medicine. Parkinson’s disease is characterized by the gradual loss of dopaminergic neurons in the…

Continue Reading